These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34168368)
1. Rapid generation of potent antibodies by autonomous hypermutation in yeast. Wellner A; McMahon C; Gilman MSA; Clements JR; Clark S; Nguyen KM; Ho MH; Hu VJ; Shin JE; Feldman J; Hauser BM; Caradonna TM; Wingler LM; Schmidt AG; Marks DS; Abraham J; Kruse AC; Liu CC Nat Chem Biol; 2021 Oct; 17(10):1057-1064. PubMed ID: 34168368 [TBL] [Abstract][Full Text] [Related]
2. Rapid generation of potent antibodies by autonomous hypermutation in yeast. Wellner A; McMahon C; Gilman MSA; Clements JR; Clark S; Nguyen KM; Ho MH; Shin JE; Feldman J; Hauser BM; Caradonna TM; Wingler LM; Schmidt AG; Marks DS; Abraham J; Kruse AC; Liu CC bioRxiv; 2020 Nov; ():. PubMed ID: 33200136 [TBL] [Abstract][Full Text] [Related]
3. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries. Yuan TZ; Garg P; Wang L; Willis JR; Kwan E; Hernandez AGL; Tuscano E; Sever EN; Keane E; Soto C; Mucker EM; Fouch ME; Davidson E; Doranz BJ; Kailasan S; Aman MJ; Li H; Hooper JW; Saphire EO; Crowe JE; Liu Q; Axelrod F; Sato AK MAbs; 2022; 14(1):2002236. PubMed ID: 34967699 [TBL] [Abstract][Full Text] [Related]
4. Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago. Qiang M; Ma P; Li Y; Liu H; Harding A; Min C; Wang F; Liu L; Yuan M; Ji Q; Tao P; Shi X; Li Z; Li T; Wang X; Zhang Y; Wu NC; Lee CD; Zhu X; Gilbert-Jaramillo J; Zhang C; Saxena A; Huang X; Wang H; James W; Dwek RA; Wilson IA; Yang G; Lerner RA Adv Sci (Weinh); 2022 Jan; 9(1):e2102181. PubMed ID: 34716683 [TBL] [Abstract][Full Text] [Related]
5. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Koenig PA; Das H; Liu H; Kümmerer BM; Gohr FN; Jenster LM; Schiffelers LDJ; Tesfamariam YM; Uchima M; Wuerth JD; Gatterdam K; Ruetalo N; Christensen MH; Fandrey CI; Normann S; Tödtmann JMP; Pritzl S; Hanke L; Boos J; Yuan M; Zhu X; Schmid-Burgk JL; Kato H; Schindler M; Wilson IA; Geyer M; Ludwig KU; Hällberg BM; Wu NC; Schmidt FI Science; 2021 Feb; 371(6530):. PubMed ID: 33436526 [TBL] [Abstract][Full Text] [Related]
6. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Xu J; Xu K; Jung S; Conte A; Lieberman J; Muecksch F; Lorenzi JCC; Park S; Schmidt F; Wang Z; Huang Y; Luo Y; Nair MS; Wang P; Schulz JE; Tessarollo L; Bylund T; Chuang GY; Olia AS; Stephens T; Teng IT; Tsybovsky Y; Zhou T; Munster V; Ho DD; Hatziioannou T; Bieniasz PD; Nussenzweig MC; Kwong PD; Casellas R Nature; 2021 Jul; 595(7866):278-282. PubMed ID: 34098567 [TBL] [Abstract][Full Text] [Related]
7. Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2. Dong J; Huang B; Wang B; Titong A; Gallolu Kankanamalage S; Jia Z; Wright M; Parthasarathy P; Liu Y Sci Rep; 2020 Oct; 10(1):17806. PubMed ID: 33082473 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library. Kim YJ; Lee MH; Lee SR; Chung HY; Kim K; Lee TG; Kim DY Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671877 [TBL] [Abstract][Full Text] [Related]
16. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants. Lin WS; Chen IC; Chen HC; Lee YC; Wu SC Front Immunol; 2021; 12():795741. PubMed ID: 34925381 [TBL] [Abstract][Full Text] [Related]
17. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients. Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511 [TBL] [Abstract][Full Text] [Related]
18. Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants. Jeong BS; Cha JS; Hwang I; Kim U; Adolf-Bryfogle J; Coventry B; Cho HS; Kim KD; Oh BH MAbs; 2022; 14(1):2021601. PubMed ID: 35030983 [TBL] [Abstract][Full Text] [Related]
19. Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness. Sherwood LJ; Hayhurst A ACS Synth Biol; 2021 Feb; 10(2):379-390. PubMed ID: 33534552 [TBL] [Abstract][Full Text] [Related]
20. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice. Mamedov T; Yuksel D; Ilgın M; Gurbuzaslan I; Gulec B; Yetiskin H; Uygut MA; Islam Pavel ST; Ozdarendeli A; Mammadova G; Say D; Hasanova G Viruses; 2021 Aug; 13(8):. PubMed ID: 34452461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]